{"id":"https://openalex.org/W2430209337","doi":null,"title":"Beta-adrenoceptor antagonists in neuropsychiatry: an update.","display_name":"Beta-adrenoceptor antagonists in neuropsychiatry: an update.","publication_year":1988,"publication_date":"1988-06-01","ids":{"openalex":"https://openalex.org/W2430209337","mag":"2430209337","pmid":"https://pubmed.ncbi.nlm.nih.gov/2897959"},"language":"en","primary_location":{"id":"pmid:2897959","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2897959","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108285762","display_name":"MALCOLM H. LADER","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124357947","display_name":"University of London","ror":"https://ror.org/04cw6st05","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"M Lader","raw_affiliation_strings":["Department of Psychiatry, University of London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, University of London, England","institution_ids":["https://openalex.org/I124357947"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5108285762"],"corresponding_institution_ids":["https://openalex.org/I124357947"],"apc_list":null,"apc_paid":null,"fwci":6.8632,"has_fulltext":false,"cited_by_count":72,"citation_normalized_percentile":{"value":0.97152584,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"49","issue":"6","first_page":"213","last_page":"23"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.7378000020980835,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.7378000020980835,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.22859999537467957,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9959999918937683},{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":0.9909999966621399},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.8650000095367432},{"id":"https://openalex.org/keywords/performance-anxiety","display_name":"performance anxiety","score":0.9950000047683716},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9300000071525574},{"id":"https://openalex.org/keywords/aggression","display_name":"aggression","score":0.9829999804496765},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.9890000224113464},{"id":"https://openalex.org/keywords/somatic-symptoms","display_name":"somatic symptoms","score":0.6179999709129333}],"concepts":[{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.8458924293518066},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.6983951330184937},{"id":"https://openalex.org/C134011695","wikidata":"https://www.wikidata.org/wiki/Q2699874","display_name":"Neuropsychiatry","level":2,"score":0.6794464588165283},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6231067776679993},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5406254529953003},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.5302267670631409},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5124412178993225},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.43981289863586426},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3693861663341522},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.2845272719860077},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000374","descriptor_name":"Aggression","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011595","descriptor_name":"Psychomotor Agitation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017109","descriptor_name":"Akathisia, Drug-Induced","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2897959","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2897959","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"},{"id":"mag:2430209337","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2897959","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2071385481","https://openalex.org/W146702622","https://openalex.org/W2097444493","https://openalex.org/W4388177341","https://openalex.org/W4253835444","https://openalex.org/W2099589693","https://openalex.org/W2074908487","https://openalex.org/W2401147759","https://openalex.org/W3118556961","https://openalex.org/W1984879948"],"abstract_inverted_index":{"Although":[0],"beta-adrenoceptor":[1],"antagonists":[2],"such":[3],"as":[4],"propranolol":[5],"have":[6],"been":[7],"used":[8],"in":[9,23,76,110,124],"neuropsychiatry":[10],"for":[11,38],"more":[12],"than":[13],"20":[14],"years,":[15],"their":[16,122],"indications,":[17],"extent":[18],"of":[19,40,51,79,105,108],"efficacy,":[20,49],"and":[21,53,67,88,92,114],"place":[22],"therapy":[24],"remain":[25],"unclear.":[26],"In":[27],"this":[28],"overview,":[29],"which":[30],"concentrates":[31],"on":[32],"the":[33,41,103],"recent":[34],"literature,":[35],"four":[36],"indications":[37,57],"use":[39,104,123],"drugs":[42],"are":[43,58,74,117],"reviewed,":[44],"with":[45,119],"particular":[46],"reference":[47],"to":[48,96,99,121],"mode":[50],"action,":[52],"clinical":[54],"utility.":[55],"The":[56,69],"anxiety":[59,80],"disorders,":[60],"including":[61],"performance":[62,90],"anxiety;":[63],"schizophrenia;":[64],"aggressive":[65,125],"behavior;":[66],"akathisia.":[68],"author":[70],"concludes":[71],"that":[72,93],"beta-blockers":[73,109],"useful":[75],"some":[77],"forms":[78],"disorder,":[81],"perhaps":[82],"those":[83,100],"characterized":[84],"by":[85,89],"somatic":[86],"symptoms":[87],"anxiety,":[91],"akathisia":[94],"seems":[95],"be":[97],"responsive":[98],"drugs.":[101],"However,":[102],"high":[106],"doses":[107],"schizophrenia":[111],"remains":[112],"unestablished,":[113],"insufficient":[115],"data":[116],"available":[118],"respect":[120],"behavior.":[126]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}